MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 26 filers reported holding MOLECULIN BIOTECH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $234,000 | +21.2% | 294,513 | +23.4% | 0.00% | – |
| Q3 2020 | $193,000 | -11.9% | 238,686 | +5.0% | 0.00% | – |
| Q2 2020 | $219,000 | +184.4% | 227,313 | +79.7% | 0.00% | – |
| Q1 2020 | $77,000 | -66.5% | 126,497 | -50.0% | 0.00% | – |
| Q4 2019 | $230,000 | +64.3% | 252,994 | +100.0% | 0.00% | – |
| Q3 2019 | $140,000 | -11.4% | 126,497 | 0.0% | 0.00% | – |
| Q2 2019 | $158,000 | +54.9% | 126,497 | 0.0% | 0.00% | – |
| Q1 2019 | $102,000 | -61.1% | 126,497 | -50.0% | 0.00% | – |
| Q4 2018 | $262,000 | +29.7% | 252,994 | +100.0% | 0.00% | – |
| Q3 2018 | $202,000 | -10.6% | 126,497 | 0.0% | 0.00% | – |
| Q2 2018 | $226,000 | +46.8% | 126,497 | +47.8% | 0.00% | – |
| Q1 2018 | $154,000 | -3.1% | 85,590 | 0.0% | 0.00% | – |
| Q4 2017 | $159,000 | +13.6% | 85,590 | +45.3% | 0.00% | – |
| Q3 2017 | $140,000 | +27.3% | 58,888 | 0.0% | 0.00% | – |
| Q2 2017 | $110,000 | – | 58,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitegate Investment Counselors, Inc. | 97,000 | $174,000 | 0.04% |
| Laird Norton Wetherby Wealth Management, LLC | 19,792 | $35,000 | 0.01% |
| TRUIST FINANCIAL CORP | 90,000 | $161,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 7,000 | $13,000 | 0.00% |
| OneDigital Investment Advisors LLC | 2,800 | $5,000 | 0.00% |
| CIBC WORLD MARKET INC. | 94,850 | $170,000 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 22,000 | $39,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 17,194 | $31,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 25,000 | $45,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 7,853 | $14,000 | 0.00% |